Cargando…

PGE(2) Is Crucial for the Generation of FAST Whole- Tumor-Antigens Loaded Dendritic Cells Suitable for Immunotherapy in Glioblastoma

Dendritic cells (DC) are the most potent antigen-presenting cells, strongly inducers of T cell-mediated immune responses and, as such, broadly used as vaccine adjuvant in experimental clinical settings. DC are widely generated from human monocytes following in vitro protocols which require 5–7 days...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nava, Sara, Lisini, Daniela, Frigerio, Simona, Pogliani, Simona, Pellegatta, Serena, Gatti, Laura, Finocchiaro, Gaetano, Bersano, Anna, Parati, Eugenio Agostino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150800/ https://www.ncbi.nlm.nih.gov/pubmed/32131407 http://dx.doi.org/10.3390/pharmaceutics12030215

Ejemplares similares

An Optimized Method for Manufacturing a Clinical Scale Dendritic Cell-Based Vaccine for the Treatment of Glioblastoma
por: Nava, Sara, et al.
Publicado: (2012)

Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
por: Nava, Sara, et al.
Publicado: (2021)

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
por: Pellegatta, Serena, et al.
Publicado: (2013)

Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapy
por: Eoli, Marica, et al.
Publicado: (2019)

P12. Combination of radiotherapy and chemotherapy with dendritic cell immunotherapy in glioblastoma patients induces NK and NKT cell responses
por: Pellegatta, S, et al.
Publicado: (2014)

Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8(+) T cell activation in the presence of adjuvant temozolomide
por: Pellegatta, Serena, et al.
Publicado: (2018)

Automated Large-Scale Production of Paclitaxel Loaded Mesenchymal Stromal Cells for Cell Therapy Applications
por: Lisini, Daniela, et al.
Publicado: (2020)

Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment against Glioblastoma
por: Cuccarini, Valeria, et al.
Publicado: (2019)

ABCC3 Expressed by CD56(dim) CD16(+) NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy
por: Pellegatta, Serena, et al.
Publicado: (2019)

Clinical Management of Moyamoya Patients
por: Canavero, Isabella, et al.
Publicado: (2021)

NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
por: Speranza, Maria Carmela, et al.
Publicado: (2012)

Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres
por: Patanè, Monica, et al.
Publicado: (2013)

Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity
por: Cantini, Gabriele, et al.
Publicado: (2012)

FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration
por: Frattini, Véronique, et al.
Publicado: (2012)

Glioblastomas
por: Finocchiaro, Gaetano, et al.
Publicado: (2021)

The Octopus Trap of Takotsubo and Stroke: Genetics, Biomarkers and Clinical Management
por: Canavero, Isabella, et al.
Publicado: (2022)

A Radial Glia Gene Marker, Fatty Acid Binding Protein 7 (FABP7), Is Involved in Proliferation and Invasion of Glioblastoma Cells
por: De Rosa, Antonella, et al.
Publicado: (2012)

Understanding the Pathophysiology of Cerebral Amyloid Angiopathy
por: Gatti, Laura, et al.
Publicado: (2020)

Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and Irinotecan
por: Cuppini, Lucia, et al.
Publicado: (2013)

The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma
por: Pessina, Sara, et al.
Publicado: (2015)

Paracoccidioides brasiliensis Interferes on Dendritic Cells Maturation by Inhibiting PGE(2) Production
por: Fernandes, Reginaldo K., et al.
Publicado: (2015)

Pleiotropic effects of the COX-2/PGE2 axis in the glioblastoma tumor microenvironment
por: Dean, Phillip T., et al.
Publicado: (2023)

Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction
por: Di Ianni, Natalia, et al.
Publicado: (2021)

Correction: Paracoccidioides brasiliensis Interferes on Dendritic Cells Maturation by Inhibiting PGE2 Production
por: Fernandes, Reginaldo K., et al.
Publicado: (2015)

MET inhibition overcomes radiation resistance of glioblastoma stem‐like cells
por: De Bacco, Francesca, et al.
Publicado: (2016)

Revisiting the Immunological Aspects of Temozolomide Considering the Genetic Landscape and the Immune Microenvironment Composition of Glioblastoma
por: Di Ianni, Natalia, et al.
Publicado: (2021)

Increased serum levels of KiSS1-derived peptides in non-small cell lung cancer patient liquid biopsies and biological relevance
por: Gatti, Laura, et al.
Publicado: (2022)

Increase of Circulating Endothelial Progenitor Cells and Released Angiogenic Factors in Children with Moyamoya Arteriopathy
por: Gorla, Gemma, et al.
Publicado: (2023)

B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
por: Nehama, Dean, et al.
Publicado: (2019)

Crucial Role of Perilipin-3 (TIP47) in Formation of Lipid Droplets and PGE(2) Production in HL-60-Derived Neutrophils
por: Nose, Fuyuki, et al.
Publicado: (2013)

Geometry sensing by dendritic cells dictates spatial organization and PGE(2)-induced dissolution of podosomes
por: van den Dries, Koen, et al.
Publicado: (2011)

Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach
por: Lisini, Daniela, et al.
Publicado: (2021)

The Suitability of Glioblastoma Cell Lines as Models for Primary Glioblastoma Cell Metabolism
por: Arthurs, Anya L., et al.
Publicado: (2020)

Microduplication of 15q13.3 and Microdeletion of 18q21.32 in a Patient with Moyamoya Syndrome
por: Luisa, Sciacca Francesca, et al.
Publicado: (2018)

Correction: Sciacca, F. L., et al. Microduplication of 15q13.3 and Microdeletion of 18q21.32 in a Patient with Moyamoya Syndrome. Int. J. Mol. Sci. 2018, 19, 3675
por: Sciacca, Francesca Luisa, et al.
Publicado: (2019)

Amblyomma sculptum Salivary PGE(2) Modulates the Dendritic Cell-Rickettsia rickettsii Interactions in vitro and in vivo
por: Esteves, Eliane, et al.
Publicado: (2019)

Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme
por: Yang, Liu, et al.
Publicado: (2015)

Vascular Remodeling in Moyamoya Angiopathy: From Peripheral Blood Mononuclear Cells to Endothelial Cells
por: Tinelli, Francesca, et al.
Publicado: (2020)

Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives
por: Bersano, Anna, et al.
Publicado: (2023)

DNA Damage in Mammalian Neural Stem Cells Leads to Astrocytic Differentiation Mediated by BMP2 Signaling through JAK-STAT
por: Schneider, Leonid, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lgia5b3c4p7snp86ff0olnk5a2